The cannabinoid receptor 1 is involved in renal fibrosis during chronic allograft dysfunction: Proof of concept

12Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Chronic allograft dysfunction (CAD), defined as the replacement of functional renal tissue by extracellular matrix proteins, remains the first cause of graft loss. The aim of our study was to explore the potential role of the cannabinoid receptor 1 (CB1) during CAD. We retrospectively quantified CB1 expression and correlated it with renal fibrosis in 26 kidney-transplanted patients who underwent serial routine kidney biopsies. Whereas CB1 expression was low in normal kidney grafts, it was highly expressed during CAD, especially in tubular cells. CB1 expression significantly increased early on after transplantation, from day 0 (D0) to month 3 post-transplant (M3) (22.5% ± 15.4% vs 33.4% ± 13.8%, P

Cite

CITATION STYLE

APA

Dao, M., Lecru, L., Vandermeersch, S., Ferreira, M., Ferlicot, S., Posseme, K., … François, H. (2019). The cannabinoid receptor 1 is involved in renal fibrosis during chronic allograft dysfunction: Proof of concept. Journal of Cellular and Molecular Medicine, 23(11), 7279–7288. https://doi.org/10.1111/jcmm.14570

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free